First of its kind endometriosis diagnosis and reproductive health prediction in one simple experience backed by breakthrough science.
First of its kind endometriosis diagnosis and reproductive health prediction in one simple experience backed by breakthrough science.
Our biology is unique, yet women were excluded from clinical trials until 1993. We're diagnosed 4 years later than men for 700+ diseases and live 25% more of our lives in poor health.
This. Must. Change.
If you know there is a problem or the risk of one, you can do something about it, and by doing so, change your future.
We capture a complete view of your biology—genes, transcripts, proteins, and other molecules—to see how they interact. Tracking over time helps detect changes and identify influences, enabling personalized guidance and treatment.
We use breakthrough methods to identify risks early, even before symptoms arise.
We can tailor treatments based on your unique biology to maximize effectiveness.
We continuously track to monitor changes and adjust care for long-term wellness.
Xella’s near-term focus is on reproductive and gynecologic health, including fertility, perimenopause, gynecologic disorders, and gynecologic cancers.
Ovarian and uterine health shape your healthspan. We illuminate the unknowns in fertility and perimenopause to optimize your long-term well-being.
Factors of uterine and ovarian aging:
Effects of uterine and ovarian aging:
A better understanding of your reproductive age and contributing factors can support decision-making with:
Endometriosis takes 7-10 years to diagnose and is a leading cause of unexplained infertility. Do you experience any of these concerns?
With a simple, menstrual fluid test from Xella, individuals with endometriosis can finally get answers, and be on their way to informed treatment and personalized care.
Simple, clear reports delivered privately to guide early intervention— whether prevention, management or cure.